Doctors test donor stem cells in spine to halt debilitating MS
NCT ID NCT06592703
Summary
This is a first-of-its-kind early safety study testing whether stem cells from a healthy donor, injected into the spinal fluid, can slow the progression of primary progressive multiple sclerosis (PPMS). The trial will enroll 10 adults with PPMS to receive three injections over several months and be monitored for one year. The main goal is to check if the treatment is safe, while also looking for early signs it might help stabilize disability.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
APHP Henri Mondor
ACTIVE_NOT_RECRUITINGCréteil, France
-
CHU Rennes
RECRUITINGRennes, France
Contact
Contact
Conditions
Explore the condition pages connected to this study.